Nicotinic receptors in dementia of Alzheimer, lewy body and vascular types

Acta Neurologica Scandinavica, Supplement

Volumn 102, Issue 176, 2000, Pages 34-41

  Martin Ruiz, C ^a   Court, J ^a   Lee, M ^a   Piggott, M ^a   Johnson, M ^a   Ballard, C ^a   Kalaria, R ^a   Perry, R ^a   Perry, E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alpha 4 and alpha 7 nicotinic receptor subunits; Alzheimer's disease; Cerebral cortex; Dementia with Lewy bodies; Vascular dementia

Indexed keywords

ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; EPIBATIDINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4; RADIOLIGAND; RECEPTOR SUBUNIT; TRITIUM; UNCLASSIFIED DRUG; LIGAND;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; ISOTOPE LABELING; LIGAND BINDING; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; PARASYMPATHETIC INNERVATION; PATHOGENESIS; PRESYNAPTIC NERVE; RECEPTOR BINDING; RECEPTOR DENSITY; TEMPORAL CORTEX; VASODILATATION; FEMALE; IMMUNOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMOKING; TEMPORAL LOBE; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA, VASCULAR; FEMALE; HUMANS; IMMUNOCHEMISTRY; LEWY BODY DISEASE; LIGANDS; MALE; RECEPTORS, NICOTINIC; SMOKING; TEMPORAL LOBE; VASODILATION;

EID: 0034487372     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
2. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
3. Neuronal nicotinic receptor subtypes
4. Presynaptic nicotinic ACh receptors
5. 3H]dopamine release
6. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain
7. The fall and rise of neuronal α-bungarotoxin binding proteins
8. Distribution of nicotinic receptors in the CNS
9. Biochemical assessment of neurotransmitter and metabolic dysfunction and cerebral atrophy in Alzheimer's disease
10. The role of the nucleus basalis of Meynert and dementia: Review and reconsideration
11. Cholinergic component of dementia and aging
12. Neuroreceptor changes in Alzheimer disease
13. Nicotinic cholinergic receptors in Alzheimer's Disease
14. Postmortem stability of α-bungarotoxin binding sites in mouse and human brain
15. Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
16. Neuronal nicotinic receptors in the human brain
17. Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization
18. Nicotine receptors are located on lateral geniculate nucleus terminals in cat visual cortex
19. Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: Evidence from thalamic and cortical lesions
20. Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis
21. Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in the hippocampus and neocortex
22. 3H]nicotine
23. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology
24. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types
25. Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia
26. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is upregulated by chronic nicotine treatment
27. Differential regulation of neuronal receptor binding sites following chronic nicotine administration
28. Identification of four classes of brain nicotinic receptors using beta 2 mutant mice
29. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains
30. Quantitative assessment of nicotinic acetylcholine receptors proteins in the cerebral cortex of Alzheimer's patients
31. α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease
32. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
33. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain
34. Nucleus basalis lesions decrease α and κ-bungarotoxins binding in rat cortex
35. Nicotinic receptor subtypes in human brain ageing, Alzheimer's and Lewy body diseases
36. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease - Histotopographical correlation with amyloid plaques and hyperphosphorylated tauprotein
37. Choline acetyltransferase and glutamic acid decarbaoxylase activities in necropsy and brain tissue
38. The neurochemistry of vascular dementia
39. 3H]Hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multiinfarct dementia
40. Cholinergic component of vascular dementia
41. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly
42. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
43. Neuropathological substrates of dementia and depression in vascular dementia with particular attention on cases with small infarct volumes
44. Protein Measurement with the Folin phenol reagent
45. Nicotinic cholinergic receptors associated with mammalian cerebral vessels
46. Human vascular endothelial cells express functional nicotinic acetylcholine receptors
47. 11C-nicotine binding in normal and Alzheimer brains-in vivo assessment using positron emission tomography
48. Correlations of nicotinic binding with neurochemical markers in Alzheimer's disease
49. Beta-amyloid (1-42) binds to alpha nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology